Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)
CNY 34.83
(-0.46%)
CNY 34.83
(-0.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.38 Billion CNY | 8.61% |
| 2022 | 2.09 Billion CNY | 14.54% |
| 2021 | 1.82 Billion CNY | -19.26% |
| 2020 | 2.26 Billion CNY | -12.46% |
| 2019 | 2.58 Billion CNY | 33.63% |
| 2018 | 1.93 Billion CNY | 61.68% |
| 2017 | 1.19 Billion CNY | 12.55% |
| 2016 | 1.06 Billion CNY | 30.96% |
| 2015 | 813.03 Million CNY | -3.68% |
| 2014 | 844.14 Million CNY | 16.65% |
| 2013 | 723.63 Million CNY | 21.06% |
| 2012 | 597.75 Million CNY | 48.15% |
| 2011 | 403.48 Million CNY | 5.65% |
| 2010 | 381.88 Million CNY | 11.11% |
| 2009 | 343.69 Million CNY | 37.88% |
| 2008 | 249.27 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 782.63 Million CNY | 17.18% |
| 2024 Q1 | 507.49 Million CNY | -23.9% |
| 2024 Q2 | 667.9 Million CNY | 31.61% |
| 2023 Q4 | 666.84 Million CNY | -7.0% |
| 2023 FY | 2.27 Billion CNY | 8.61% |
| 2023 Q1 | 454.06 Million CNY | -32.52% |
| 2023 Q2 | 522.25 Million CNY | 15.02% |
| 2023 Q3 | 717.07 Million CNY | 37.3% |
| 2022 FY | 2.09 Billion CNY | 14.54% |
| 2022 Q2 | 467.94 Million CNY | 19.43% |
| 2022 Q4 | 672.83 Million CNY | 19.42% |
| 2022 Q3 | 563.41 Million CNY | 20.4% |
| 2022 Q1 | 391.82 Million CNY | -36.2% |
| 2021 Q3 | 393.57 Million CNY | 23.75% |
| 2021 Q4 | 614.17 Million CNY | 56.05% |
| 2021 FY | 1.82 Billion CNY | -19.26% |
| 2021 Q1 | 504.07 Million CNY | -15.9% |
| 2021 Q2 | 318.05 Million CNY | -36.9% |
| 2020 Q4 | 599.38 Million CNY | -7.23% |
| 2020 Q1 | 406.67 Million CNY | -40.19% |
| 2020 Q3 | 646.12 Million CNY | 5.2% |
| 2020 FY | 2.26 Billion CNY | -12.46% |
| 2020 Q2 | 614.17 Million CNY | 51.02% |
| 2019 Q1 | 504.02 Million CNY | -17.02% |
| 2019 Q3 | 726.49 Million CNY | 7.04% |
| 2019 Q4 | 679.9 Million CNY | -6.41% |
| 2019 FY | 2.58 Billion CNY | 33.63% |
| 2019 Q2 | 678.68 Million CNY | 34.65% |
| 2018 Q2 | 432.65 Million CNY | 38.08% |
| 2018 Q4 | 607.43 Million CNY | 4.0% |
| 2018 FY | 1.93 Billion CNY | 61.68% |
| 2018 Q1 | 313.33 Million CNY | 12.28% |
| 2018 Q3 | 584.08 Million CNY | 35.0% |
| 2017 Q1 | 215.3 Million CNY | -44.45% |
| 2017 FY | 1.19 Billion CNY | 12.55% |
| 2017 Q2 | 459.02 Million CNY | 113.2% |
| 2017 Q4 | 279.07 Million CNY | 13.92% |
| 2017 Q3 | 244.97 Million CNY | -46.63% |
| 2016 Q3 | 202.37 Million CNY | -42.98% |
| 2016 Q1 | 119.85 Million CNY | -53.37% |
| 2016 Q4 | 387.56 Million CNY | 91.51% |
| 2016 FY | 1.06 Billion CNY | 30.96% |
| 2016 Q2 | 354.93 Million CNY | 196.15% |
| 2015 Q4 | 257 Million CNY | 45.65% |
| 2015 Q3 | 176.44 Million CNY | -15.22% |
| 2015 Q2 | 208.12 Million CNY | 21.38% |
| 2015 Q1 | 171.46 Million CNY | -27.86% |
| 2015 FY | 813.03 Million CNY | -3.68% |
| 2014 Q2 | 223.07 Million CNY | 45.09% |
| 2014 FY | 844.14 Million CNY | 16.65% |
| 2014 Q4 | 237.66 Million CNY | 3.48% |
| 2014 Q3 | 229.66 Million CNY | 2.95% |
| 2014 Q1 | 153.74 Million CNY | -19.73% |
| 2013 Q2 | 202.87 Million CNY | 49.44% |
| 2013 Q4 | 191.53 Million CNY | -1.0% |
| 2013 FY | 723.63 Million CNY | 21.06% |
| 2013 Q1 | 135.75 Million CNY | -35.24% |
| 2013 Q3 | 193.46 Million CNY | -4.64% |
| 2012 FY | 597.75 Million CNY | 48.15% |
| 2012 Q2 | 156.5 Million CNY | 109.03% |
| 2012 Q3 | 156.74 Million CNY | 0.15% |
| 2012 Q4 | 209.62 Million CNY | 33.74% |
| 2012 Q1 | 74.87 Million CNY | -49.74% |
| 2011 FY | 403.48 Million CNY | 5.65% |
| 2011 Q4 | 148.96 Million CNY | 68.75% |
| 2011 Q3 | 88.27 Million CNY | -21.26% |
| 2011 Q2 | 112.1 Million CNY | 107.06% |
| 2011 Q1 | 54.14 Million CNY | -59.15% |
| 2010 Q3 | 88.22 Million CNY | 0.0% |
| 2010 FY | 381.88 Million CNY | 11.11% |
| 2010 Q4 | 132.54 Million CNY | 50.25% |
| 2009 FY | 343.69 Million CNY | 37.88% |
| 2008 FY | 249.27 Million CNY | 0.0% |